Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Adicet Bio, Inc.Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus NephritisREDWOOD CITY, Calif., September 25, 2026--Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the Company will report clinical data from the Phase 1 study evaluating prulacabtagene leucel (prula-cel) as a potential treatment for patients with systemic lupus erythematosus with or without lupus nephriti
- HIMS Stockholders Have Rights – If You Lost Money Investing in Hims & Hers Health, Inc. Contact Robbins LLP for Information About Recovering Your LossesRobbins LLP is Investigating Allegations that Hims & Hers Health, Inc. Shared Customers' Protected Information With Advertising Platforms
- Pennsylvania Trauma Systems FoundationPennsylvania Trauma Systems Foundation Approval for Elevation of Level II Trauma Center to a Level I StatusEffective October 1, 2026, one hospital has been approved for an elevation in trauma center level from Level II accreditation to Level I accreditation: St. Luke's Hospital – Anderson Campus - Easton, PA There are 56 accredited trauma...
- The Breast Cancer Fight You Can Join Today: One Bra Fitting at a Time: In Discussion With YourUpdateTVWacoal conducts media tour in conjunction with D S Simon Media discussing how a simple bra fitting can be an important self-care moment, while its Fit for the Cure® program helps women prioritize comfort, confidence and breast health while supporting Susan G. Komen.
- Baystate Health SystemBAYSTATE HEALTH ANNOUNCES PARTICIPATION IN NATIONAL CLINICAL TRIAL FOR ADVANCED BRAIN ANEURYSM TREATMENTFirst Hospital in the Country to Enroll Patients — Baystate Health announced today that it was selected to participate in a groundbreaking national clinical trial for Advanced Brain Aneurysm treatment and has enrolled the country's first...
- SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic CancerSELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced preclinical data from studies evaluating SLS009 (tambiciclib), its highly selective cyclin-dependent kinases 9 (CDK9) inhibitor, in patient-derived organoid models of pancreatic ductal adenocarcinoma (PDAC). The data are being presented at the American Association for Cancer Research (AACR) Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development, being held September 25–28, 2026, in San Diego. The timing of this announcement reflects AACR’s embargo policy, under which the data presented at the conference were restricted from publication until 1:00 p.m. ET today.
- InSilicoTrialsInSilicoTrials Joins ARPA-H CIRCLE Team to Build a Regulatory-Ready Platform for Critical Illness Digital TwinsWILMINGTON, Del., September 25, 2026--InSilicoTrials, a cloud-based platform for AI and computational modeling and simulation in healthcare, today announced that it is a subawardee on a team led by Sage BioNetworks, which has received an award from the Advanced Research Projects Agency for Health (ARPA-H) under the Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program.
- Parker Health GroupParker Health Group Names Mark Lenhard as Next President & CEOExperienced aging services executive will succeed renowned leader Roberto Muñiz — Parker Health Group, a nationally recognized nonprofit provider of aging services, announced today that Mark Lenhard, MS, LNFA, has been named its next...
- The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipientAJMC names Aaron L. Schwartz, M.D., Ph.D., recipient of the 2026 Seema S. Sonnad Emerging Leader in Managed Care Research Award for health care research
- Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDSPharming announces US FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children aged 4 years older
- Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service PartnerFangzhou has released its 2026 interim report, highlighting continued progress in its “AI + Chronic Disease Services” strategy.
- Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026Company to feature surgeon-led educational programming and technologies supporting liver surgery